System Transmission

Top Signal

100#1 JOB

Activity

2169Ripe

+910 today

System

Livenow

Terminal Asset View

stockNASDAQ

ACLX

$114.39+0.09%

Arcellx Inc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

44Neutral

Live Analysis Active

Company Mission

Arcellx develops cell therapies that reprogram a patient's own immune cells to recognize and attack cancer cells. These treatments are being tested in clinical trials for various cancers. The company makes money through research partnerships with larger pharmaceutical companies and could earn revenue from drug sales if treatments receive regulatory approval.

ACL

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Cancer immunotherapy has become a major area of research, with companies creating treatments that help the body's own immune system fight cancer cells. This sector experiences periods of high investor interest when new treatments show promise in clinical trials.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

30Matrix

Market Momentum

83.6— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.2x— Normal Volume

Today's Change

0.09%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-0

Price is extended significantly above 52-week highs.

RSI Saturation-0

Momentum is saturated (Overbought). High risk of mean reversion.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ACLX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:08 PM UTC

As-of 03-15-2026 16:53 UTC

Develops cell therapies that fight cancer by reprogramming immune cells and earns money through partnerships and future drug sales.

Price momentum extended as it trades near its yearly high, suggesting the stock may be due for a pause or pullback.

Biotech sector showing renewed interest in cancer immunotherapy, which could benefit companies developing novel cell-based treatments.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...